Cuffe Michael S.
EVP and Chief Clinical Officer
Cuffe Michael S. has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Feb 12, 2026.
On the most recent filing, Cuffe Michael S. is listed as EVP and Chief Clinical Officer at HCA Healthcare, Inc. Inside the rolling window, Cuffe Michael S. reported no open-market purchases and 1 open-market sale totaling $747K in HCA.
Companies traded
Other insiders at HCA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$747K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 8, 2025 | HCA | Sale | $1.6M |
Frequently asked questions
How many SEC Form 4 filings has Cuffe Michael S. made?
Cuffe Michael S. has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Cuffe Michael S. trade?
Cuffe Michael S. has filed SEC Form 4 disclosures for 1 company, including HCA.
When was Cuffe Michael S.'s most recent SEC Form 4 filing?
Cuffe Michael S.'s most recent SEC Form 4 filing on Tracefour is dated Feb 12, 2026.
What is Cuffe Michael S.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cuffe Michael S. is listed as EVP and Chief Clinical Officer.
What is Cuffe Michael S.'s total buy and sell value in the current window?
Inside the rolling retention window, Cuffe Michael S. bought $0 and sold $747K based on SEC Form 4 filings.
What was Cuffe Michael S.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,500 HCA shares on 2026-02-03, worth $747K, per SEC Form 4 filings.